AUDREY / EOCRC2-22
Cancer colorectal métastatique-pMMR ou MSS-vaccin-immunothérapie
A global mUlticenter phase 1/2 trial of EO4010, a novel microbial-Derived peptide theRapeutic vaccine, in combination with nivolumab, for trEatment of patients with previouslY treated metastatic colorectal carcinoma